205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-6.58%
Both yoy net incomes decline, with AVGO at -9.78%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
28.92%
Well above AVGO's 18.76% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
67.57%
Growth well above AVGO's 68.61%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-73.06%
Both negative yoy, with AVGO at -33.99%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-58.68%
Negative yoy CFO while AVGO is 7.23%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-23.75%
Both yoy lines negative, with AVGO at -44.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-22.17%
Negative yoy purchasing while AVGO stands at 45.71%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
105.70%
Below 50% of AVGO's 333.33%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
No Data
No Data available this quarter, please select a different quarter.
48.32%
Investing outflow well above AVGO's 23.56%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-24.19%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-17.86%
Both yoy lines negative, with AVGO at -107.07%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.